Evidence map›Paper›PMID 38338877›Full record

ArticleInternational journal of molecular sciences2024

Antimicrobial Activity of Synthetic Enterocins A, B, P, SEK4, and L50, Alone and in Combinations, against

Sara García-Vela, Louis-David Guay, Md Ramim Tanver Rahman, Eric Biron, Carmen Torres, Ismail Fliss

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. FirstMicrobiology spectrum · 2026
    Article
  3. Article
  4. Article
  5. Bioprotective Strategies to ControlInternational journal of molecular sciences · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Absent in Melanoma 2 Mediates Inflammasome Signaling Activation againstInternational journal of molecular sciences · 2024
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sara García-VelaArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, 26006 Logrono, La Rioja, Spain.
Louis-David GuayInstitute of Nutrition and Functional Foods, Laval University, Quebec, QC G1V 0A6, Canada.ORCID 0000-0001-8328-7550
Md Ramim Tanver RahmanInstitute of Nutrition and Functional Foods, Laval University, Quebec, QC G1V 0A6, Canada.
Eric BironInstitute of Nutrition and Functional Foods, Laval University, Quebec, QC G1V 0A6, Canada.ORCID 0000-0002-8030-6741
Carmen TorresArea of Biochemistry and Molecular Biology, OneHealth-UR Research Group, University of La Rioja, 26006 Logrono, La Rioja, Spain.ORCID 0000-0003-3709-1690
Ismail FlissDepartment of Food Science, Laval University, Quebec, QC G1V 0A6, Canada.
Université Laval · CAUniversidad de La Rioja · ES

Funding

International Development Research Centre Avibiocin I
6 · The paper itself

Abstract

Multidrug-resistant

Indexed as

BacteriocinsMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsBridged-Ring CompoundsClostridium perfringensMicrobial Sensitivity TestsAnti-Bacterial AgentsBacteriocinsBridged-Ring Compoundsenterocinantimicrobial activitychemical synthesisClostridium perfringensenterocinssynergy

Identifiers

PMID38338877
PMCPMC10855908
OpenAlexW4391322167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.